股本结构
单位：万股
| 公告日期 | 2026-03-05 | 2026-03-05 | 2025-11-06 | 2025-10-16 | 2025-10-16 | 2025-11-06 |
|---|---|---|---|---|---|---|
| 证券总股本 | 8343.20 | 8282.64 | 8278.72 | 8071.55 | 6971.55 | 6956.98 |
| 普通股本 | 8343.20 | 8282.64 | 8278.72 | 8071.55 | 6971.55 | 6956.98 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-02-27 | 2025-12-31 | 2025-10-30 | 2025-10-16 | 2025-10-06 | 2025-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-03-05 | 8343.20 | 未披露 | 定期报告 | 2026-02-27 |
| 2026-03-05 | 8282.64 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
Stock units granted, net of units withheld for tax
|
2025-12-31 |
| 2025-11-06 | 8278.72 | 未披露 | 定期报告 | 2025-10-30 |
| 2025-10-16 | 8071.55 | 未披露 |
更多>>
Common Stock offered 11,000,000 shares by the company
|
2025-10-16 |
| 2025-10-16 | 6971.55 | 未披露 | 定期报告 | 2025-10-06 |
| 2025-11-06 | 6956.98 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2025-09-30 |
| 2025-08-07 | 6892.74 | 未披露 | 定期报告 | 2025-07-31 |
| 2025-08-07 | 6888.96 | 未披露 |
更多>>
From April 1, 2025 to June 30, 2025
Vesting of stock units
Exercise of stock options
|
2025-06-30 |
| 2025-05-08 | 6881.17 | 未披露 | 定期报告 | 2025-05-01 |
| 2025-05-08 | 6881.14 | 未披露 |
更多>>
From January 1, 2025 to March 31, 2025
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2025-03-31 |
| 2025-03-06 | 6872.88 | 未披露 | 定期报告 | 2025-02-28 |
| 2025-03-06 | 6826.60 | 未披露 |
更多>>
From January 1, 2024 to December 31, 2024
Issuance of stock, net of issue costs
Cashless exercise of warrants
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2024-12-31 |
| 2024-11-07 | 6825.10 | 未披露 |
更多>>
Common stock offered 12,727,273 shares by the company
|
2024-10-31 |
| 2024-11-07 | 5352.44 | 未披露 |
更多>>
From July 1, 2024 to September 30, 2024
Issuance of stock, net of issue costs
Cashless exercise of warrants
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2024-09-30 |
| 2024-08-08 | 5351.82 | 未披露 | 定期报告 | 2024-08-02 |
| 2024-08-08 | 5216.03 | 未披露 |
更多>>
From April 1, 2024 to June 30, 2024
Cashless exercise of warrants
Employee stock purchase plan
Vesting of stock units
|
2024-06-30 |
| 2024-05-09 | 5208.44 | 未披露 | 定期报告 | 2024-05-02 |
| 2024-04-26 | 5208.41 | 未披露 | 定期报告 | 2024-04-23 |
| 2024-05-09 | 4988.57 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Cashless exercise of warrants
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2024-03-31 |
| 2024-05-09 | 4983.08 | 未披露 |
更多>>
From January 1, 2024 to March 1, 2024
Cashless exercise of warrants
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2024-03-01 |
| 2024-03-08 | 4904.31 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2023-12-31 |
| 2023-12-07 | 4707.41 | 未披露 |
更多>>
Common stock offered 11,764,706 shares by the company
|
2023-12-08 |
| 2023-11-03 | 3530.94 | 未披露 |
更多>>
From July 1, 2023 to September 30, 2023
Vesting of stock units
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
|
2023-09-30 |
| 2023-08-04 | 3498.40 | 未披露 | 定期报告 | 2023-07-28 |
| 2023-08-04 | 3430.61 | 未披露 |
更多>>
From April 1, 2023 to June 30, 2023
Exercise of stock options
Vesting of stock units
Employee stock purchase plan
|
2023-06-30 |
| 2023-05-04 | 3430.19 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Employee stock purchase plan
Vesting of stock units
|
2023-03-31 |
| 2023-03-10 | 3430.19 | 未披露 | 定期报告 | 2023-03-02 |
| 2023-03-10 | 3408.29 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Vesting of stock units
Employee stock purchase plan
Exercise of stock options
|
2022-12-31 |
| 2022-11-04 | 3408.29 | 未披露 | 定期报告 | 2022-11-01 |
| 2022-11-04 | 3407.22 | 未披露 |
更多>>
From July 1, 2022 to September 30, 2022
Employee stock purchase plan
Exercise of stock options
|
2022-09-30 |
| 2022-09-28 | 3407.22 | 未披露 | 定期报告 | 2022-09-23 |
| 2022-08-05 | 3407.19 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-08-05 | 3405.26 | 未披露 |
更多>>
From April 1, 2022 to June 30, 2022
Vesting of stock units
|
2022-06-30 |
| 2022-05-06 | 3404.71 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2022-03-31 |
| 2022-03-14 | 3404.43 | 未披露 | 定期报告 | 2022-03-04 |
| 2022-03-14 | 3390.58 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of stock and pre-funded warrants, net of issue costs
Exercise of stock options
Employee stock purchase plan
Vesting of stock units
|
2021-12-31 |
| 2021-11-19 | 3279.85 | 未披露 |
更多>>
1.Common stock offered by company 4,027,273 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 28,771,264 shares of common stock outstanding as of September 30, 2021.
|
2021-11-19 |
| 2021-11-05 | 2877.13 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2021-09-30 |
| 2021-08-06 | 2877.00 | 未披露 | 定期报告 | 2021-07-30 |
| 2021-08-06 | 2875.42 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Vesting of stock units
|
2021-06-30 |
| 2021-05-05 | 2874.15 | 未披露 |
更多>>
from January 1, 2021 to March 31, 2021
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
|
2021-03-31 |
| 2021-03-12 | 2874.15 | 未披露 | 定期报告 | 2021-03-05 |
| 2021-02-12 | 2868.38 | 未披露 |
更多>>
1.Common stock offered by the company 9,100,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 13,142,112 shares of common stock outstanding as of September 30, 2020.
|
2021-02-04 |
| 2021-01-15 | 1815.86 | 未披露 | 定期报告 | 2021-01-14 |
| 2021-03-12 | 1814.00 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of stock, net of issue costs
Employee stock purchase plan
Vesting of stock units
|
2020-12-31 |
| 2020-12-08 | 1513.00 | 未披露 |
更多>>
On December 8, 2020, EyePoint Pharmaceuticals, Inc. (the “Company”) announced that it filed a Certificate of Amendment of the Company’s certificate of incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, to effect a one-for-10 reverse stock split (the “reverse split”) of the Company’s issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), at 5:00 p.m. Eastern Time on that date. As a result of the reverse split, the number of issued and outstanding shares of Common Stock will be adjusted from 151.3 million shares to approximately 15.13 million shares.
|
2020-12-09 |
| 2020-11-06 | 14351.53 | 未披露 | 定期报告 | 2020-10-30 |
| 2020-10-16 | 13377.62 | 未披露 | 定期报告 | 2020-10-15 |
| 2020-11-06 | 13142.18 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of stock, net of issue costs
Employee stock purchase plan
Vesting of stock units
|
2020-09-30 |
| 2020-08-05 | 12521.71 | 未披露 | 定期报告 | 2020-07-30 |
| 2020-08-05 | 12519.79 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Vesting of stock units
|
2020-06-30 |
| 2020-05-08 | 12474.18 | 未披露 |
更多>>
From January 1, 2020 to March 31, 2020
Issuance of stock, net of issue costs
Employee stock purchase plan
Vesting of stock units
|
2020-03-31 |
| 2020-03-16 | 12474.18 | 未披露 | 定期报告 | 2020-03-05 |
| 2020-02-25 | 12302.92 | 未披露 | 定期报告 | 2020-02-25 |
| 2020-03-16 | 10941.73 | 未披露 |
更多>>
From March 31, 2018 To December 31, 2019
Exercise of stock options
Vesting of stock units
Issuance of stock, net of issue costs
|
2019-12-31 |
| 2019-11-07 | 10811.74 | 未披露 | 定期报告 | 2019-11-04 |
| 2019-11-07 | 10802.92 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Issuance of stock, net of issue costs
Vesting of stock units
|
2019-09-30 |
| 2019-08-07 | 10629.78 | 未披露 |
更多>>
From March 31, 2019 To June 30, 2019
Issuance of stock, net of issue costs
Exercise of stock options
Vesting of stock units
|
2019-06-30 |
| 2019-04-29 | 10610.57 | 未披露 | 定期报告 | 2019-04-26 |
| 2019-05-10 | 9555.42 | 未披露 |
更多>>
From March 31, 2018 To March 31, 2019
Exercise of stock options
Vesting of stock units
|
2019-03-31 |
| 2019-03-18 | 9537.42 | 未披露 | 定期报告 | 2019-03-13 |
| 2019-03-18 | 9537.22 | 未披露 |
更多>>
From June 30, 2018 To December 31, 2018
Exercise of warrants
Exercise of stock options
Vesting of stock units
|
2018-12-31 |
| 2018-11-28 | 9497.87 | 未披露 | 定期报告 | 2018-11-16 |
| 2018-10-29 | 9485.57 | 未披露 | 定期报告 | 2018-10-22 |
| 2018-11-09 | 9469.63 | 未披露 |
更多>>
From July 1, 2018 to September 30, 2018
Exercise of warrants
|
2018-09-30 |
| 2018-09-18 | 7451.20 | 未披露 |
更多>>
From June 30, 2017 to June 30, 2018
Issuance of stock, net of issue costs
Exercise of stock options
Vesting of stock units
|
2018-06-30 |
| 2018-05-10 | 5402.99 | 未披露 | 定期报告 | 2018-05-07 |
| 2018-05-10 | 5390.99 | 未披露 |
更多>>
From July 1, 2017 To March 31, 2018
Issuance of stock, net of issue costs
Vesting of performance stock units
|
2018-03-31 |
| 2018-02-08 | 4525.70 | 未披露 |
更多>>
From July 1, 2017 To December 31, 2017
Issuance of stock, net of issue costs
|
2017-12-31 |
| 2017-11-08 | 4525.70 | 未披露 |
更多>>
From October 1, 2017 to November 7, 2017, we sold an additional 5,056,216 shares of common stock under the ATM program for gross proceeds of approximately $6.2 million.
|
2017-11-07 |
| 2017-10-30 | 4516.44 | 未披露 | 定期报告 | 2017-10-26 |
| 2017-10-30 | 4501.89 | 未披露 | 定期报告 | 2017-10-25 |
| 2017-11-08 | 4020.08 | 未披露 |
更多>>
From July 1, 2017 To September 30, 2017
Issuance of stock, net of issue costs
|
2017-09-30 |
| 2017-09-13 | 3937.26 | 未披露 | 定期报告 | 2017-09-08 |
| 2017-09-13 | 3935.70 | 未披露 |
更多>>
From June 30, 2016 to June 30, 2017
Issuance of stock, net of issue costs
Exercise of stock options
|
2017-06-30 |
| 2017-05-15 | 3935.70 | 未披露 | 定期报告 | 2017-05-10 |
| 2017-05-08 | 3926.87 | 未披露 | 定期报告 | 2017-05-04 |
| 2017-05-08 | 3566.87 | 未披露 |
更多>>
from July 1, 2016 to March 31, 2017
Issuance of stock, net of issue costs
Exercise of stock options
|
2017-03-31 |
| 2016-11-08 | 3417.70 | 未披露 |
更多>>
from July 1, 2016 to September 30, 2016
Exercise of stock options
|
2016-09-30 |
| 2016-09-13 | 3417.70 | 未披露 | 定期报告 | 2016-09-06 |
| 2016-09-13 | 3417.29 | 未披露 |
更多>>
From June 30, 2015 to June 30, 2016
Issuance of stock, net of issue costs
Exercise of stock options
|
2016-06-30 |
| 2016-05-06 | 3417.29 | 未披露 | 定期报告 | 2016-05-04 |
| 2016-05-06 | 3408.29 | 未披露 |
更多>>
from July 1, 2015 to March 31, 2016
Issuance of stock, net of issue costs
Exercise of stock options
|
2016-03-31 |
| 2016-02-09 | 3407.29 | 未披露 | 定期报告 | 2016-02-04 |
| 2016-02-09 | 2962.79 | 未披露 |
更多>>
from July 1, 2015 to December 31, 2015
Exercise of stock options
|
2015-12-31 |
| 2015-11-06 | 2941.74 | 未披露 |
更多>>
from July 1, 2015 to September 30, 2015
Exercise of stock options
|
2015-09-30 |
| 2015-09-10 | 2941.74 | 未披露 | 定期报告 | 2015-09-04 |
| 2015-02-06 | 2941.24 | 未披露 |
更多>>
from July 1, 2014 to December 31, 2014
Exercise of stock options
|
2014-12-31 |
| 2014-10-24 | 2934.76 | 未披露 | 定期报告 | 2014-10-21 |
| 2014-11-07 | 2933.76 | 未披露 |
更多>>
from July 1, 2014 to September 30, 2014
Exercise of stock option
|
2014-09-30 |
| 2014-09-11 | 2933.76 | 未披露 | 定期报告 | 2014-09-08 |
| 2014-09-11 | 2929.86 | 未披露 |
更多>>
from June 30, 2013 to June 30, 2014
Issuance of stock, net of issue costs
Exercise of stock options
|
2014-06-30 |
| 2014-05-14 | 2925.25 | 未披露 | 定期报告 | 2014-05-09 |
| 2014-05-14 | 2924.46 | 未披露 |
更多>>
from July 1, 2013 to March 31, 2014
Issuance of stock, net of issue costs
Exercise of stock options
|
2014-03-31 |
| 2014-02-12 | 2735.64 | 未披露 | 定期报告 | 2014-02-07 |
| 2014-02-12 | 2729.86 | 未披露 |
更多>>
from July 1, 2013 to December 31, 2013
Issuance of stock, net of issue costs
Exercise of stock options
|
2013-12-31 |
| 2013-10-25 | 2696.31 | 未披露 | 定期报告 | 2013-10-21 |
| 2013-11-13 | 2679.16 | 未披露 |
更多>>
from July 1, 2013 to September 23, 2013
Issuance of stock, net of issue costs
|
2013-09-23 |
| 2012-11-09 | 2329.70 | 未披露 |
更多>>
from July 1, 2012 to September 24, 2012
Issuance of stock, net of issue costs
|
2012-09-24 |
| 2011-11-08 | 2080.26 | 未披露 |
更多>>
from June 30, 2010 to September 30, 2011
Exercise of stock options
|
2011-09-30 |
| 2011-09-13 | 2075.06 | 未披露 | 定期报告 | 2011-09-09 |
| 2011-09-13 | 2074.86 | 未披露 |
更多>>
from June 30, 2010 to June 30, 2011
Issuance of stock, net of issue costs
Exercise of stock options
|
2011-06-30 |
| 2011-05-11 | 2074.26 | 未披露 |
更多>>
From July 1, 2010 to March 31, 2011
Stock issued, net of issue costs
Exercise of stock options
|
2011-03-31 |
| 2011-02-10 | 2074.14 | 未披露 | 定期报告 | 2011-02-07 |
| 2010-05-13 | 1853.14 | 未披露 |
更多>>
From July 1, 2009 to March 31, 2010
Exercise of warrants
Exercise of stock options
Issuance of fully vested shares
|
2010-03-31 |
From December 31, 2024 to December 31, 2025
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
Stock units granted, net of units withheld for tax
Common Stock offered 11,000,000 shares by the company
From June 30, 2025 to September 30, 2025
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
From April 1, 2025 to June 30, 2025
Vesting of stock units
Exercise of stock options
From January 1, 2025 to March 31, 2025
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
From January 1, 2024 to December 31, 2024
Issuance of stock, net of issue costs
Cashless exercise of warrants
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
Common stock offered 12,727,273 shares by the company
From July 1, 2024 to September 30, 2024
Issuance of stock, net of issue costs
Cashless exercise of warrants
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
From April 1, 2024 to June 30, 2024
Cashless exercise of warrants
Employee stock purchase plan
Vesting of stock units
From December 31, 2023 to March 31, 2024
Cashless exercise of warrants
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
From January 1, 2024 to March 1, 2024
Cashless exercise of warrants
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
From December 31,2022 to December 31,2023
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
Common stock offered 11,764,706 shares by the company
From July 1, 2023 to September 30, 2023
Vesting of stock units
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
From April 1, 2023 to June 30, 2023
Exercise of stock options
Vesting of stock units
Employee stock purchase plan
From January 1, 2023 to March 31, 2023
Employee stock purchase plan
Vesting of stock units
From December 31, 2021 to December 31, 2022
Vesting of stock units
Employee stock purchase plan
Exercise of stock options
From July 1, 2022 to September 30, 2022
Employee stock purchase plan
Exercise of stock options
From April 1, 2022 to June 30, 2022
Vesting of stock units
From January 1, 2022 to March 31, 2022
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
From December 31, 2020 to December 31, 2021
Issuance of stock and pre-funded warrants, net of issue costs
Exercise of stock options
Employee stock purchase plan
Vesting of stock units
1.Common stock offered by company 4,027,273 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 28,771,264 shares of common stock outstanding as of September 30, 2021.
From June 30, 2021 to September 30, 2021
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
From March 31, 2021 to June 30, 2021
Vesting of stock units
from January 1, 2021 to March 31, 2021
Issuance of stock, net of issue costs
Employee stock purchase plan
Exercise of stock options
Vesting of stock units
1.Common stock offered by the company 9,100,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 13,142,112 shares of common stock outstanding as of September 30, 2020.
From December 31, 2019 to December 31, 2020
Issuance of stock, net of issue costs
Employee stock purchase plan
Vesting of stock units
On December 8, 2020, EyePoint Pharmaceuticals, Inc. (the “Company”) announced that it filed a Certificate of Amendment of the Company’s certificate of incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware, to effect a one-for-10 reverse stock split (the “reverse split”) of the Company’s issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), at 5:00 p.m. Eastern Time on that date. As a result of the reverse split, the number of issued and outstanding shares of Common Stock will be adjusted from 151.3 million shares to approximately 15.13 million shares.
From June 30, 2020 to September 30, 2020
Issuance of stock, net of issue costs
Employee stock purchase plan
Vesting of stock units
From March 31, 2020 to June 30, 2020
Vesting of stock units
From January 1, 2020 to March 31, 2020
Issuance of stock, net of issue costs
Employee stock purchase plan
Vesting of stock units
From March 31, 2018 To December 31, 2019
Exercise of stock options
Vesting of stock units
Issuance of stock, net of issue costs
From June 30, 2019 to September 30, 2019
Issuance of stock, net of issue costs
Vesting of stock units
From March 31, 2019 To June 30, 2019
Issuance of stock, net of issue costs
Exercise of stock options
Vesting of stock units
From March 31, 2018 To March 31, 2019
Exercise of stock options
Vesting of stock units
From June 30, 2018 To December 31, 2018
Exercise of warrants
Exercise of stock options
Vesting of stock units
From July 1, 2018 to September 30, 2018
Exercise of warrants
From June 30, 2017 to June 30, 2018
Issuance of stock, net of issue costs
Exercise of stock options
Vesting of stock units
From July 1, 2017 To March 31, 2018
Issuance of stock, net of issue costs
Vesting of performance stock units
From July 1, 2017 To December 31, 2017
Issuance of stock, net of issue costs
From October 1, 2017 to November 7, 2017, we sold an additional 5,056,216 shares of common stock under the ATM program for gross proceeds of approximately $6.2 million.
From July 1, 2017 To September 30, 2017
Issuance of stock, net of issue costs
From June 30, 2016 to June 30, 2017
Issuance of stock, net of issue costs
Exercise of stock options
from July 1, 2016 to March 31, 2017
Issuance of stock, net of issue costs
Exercise of stock options
from July 1, 2016 to September 30, 2016
Exercise of stock options
From June 30, 2015 to June 30, 2016
Issuance of stock, net of issue costs
Exercise of stock options
from July 1, 2015 to March 31, 2016
Issuance of stock, net of issue costs
Exercise of stock options
from July 1, 2015 to December 31, 2015
Exercise of stock options
from July 1, 2015 to September 30, 2015
Exercise of stock options
from July 1, 2014 to December 31, 2014
Exercise of stock options
from July 1, 2014 to September 30, 2014
Exercise of stock option
from June 30, 2013 to June 30, 2014
Issuance of stock, net of issue costs
Exercise of stock options
from July 1, 2013 to March 31, 2014
Issuance of stock, net of issue costs
Exercise of stock options
from July 1, 2013 to December 31, 2013
Issuance of stock, net of issue costs
Exercise of stock options
from July 1, 2013 to September 23, 2013
Issuance of stock, net of issue costs
from July 1, 2012 to September 24, 2012
Issuance of stock, net of issue costs
from June 30, 2010 to September 30, 2011
Exercise of stock options
from June 30, 2010 to June 30, 2011
Issuance of stock, net of issue costs
Exercise of stock options
From July 1, 2010 to March 31, 2011
Stock issued, net of issue costs
Exercise of stock options
From July 1, 2009 to March 31, 2010
Exercise of warrants
Exercise of stock options
Issuance of fully vested shares